NeuroSense Therapeutics (NRSN) Interest Expenses (2021 - 2023)
NeuroSense Therapeutics' (NRSN) quarterly Interest Expenses came in at $2.7 million in Q4 2023, up 2638.14% year-over-year from $97000.0 in Q4 2022, and up 22233.33% quarter-over-quarter from -$12000.0 in Q3 2023.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Interest Expenses (2021 - 2023) Analysis & Trends
NeuroSense Therapeutics has disclosed Interest Expenses across 3 years of filings, most recently posting $2.7 million for Q4 2023.
- In Q4 2023, Interest Expenses rose 2638.14% year-over-year to $2.7 million; the TTM figure through Dec 2023 stood at $448000.0 (up 1444.83% YoY), while the FY2025 annual figure was $53000.0, down 85.11% from the prior year.
- Interest Expenses came in at $2.7 million for Q4 2023 at NeuroSense Therapeutics, up from -$12000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.7 million in Q4 2023 to a low of -$1.9 million in Q2 2023.
- Average Interest Expenses over 3 years is -$78666.7, with a median of -$23000.0 recorded in 2022.
- The largest YoY upside for Interest Expenses was 2638.14% in 2023 against a maximum downside of 5288.57% in 2023.
- Over 3 years, Interest Expenses stood at -$1.2 million in 2021, then surged by 108.19% to $97000.0 in 2022, then jumped by 2638.14% to $2.7 million in 2023.
- Per Business Quant data, the three most recent Interest Expenses figures were $2.7 million in Q4 2023, -$12000.0 in Q3 2023, and -$1.9 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -1.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | -1.89 Mn |
| Mar 31, 2023 | -310,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -1.19 Mn |
API Access
NeuroSense Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();